XML 19 R12.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Fair Value Measurements | 3 Months Ended
--- | ---
Mar. 31, 2024
Fair Value Disclosures [Abstract] |
Fair Value Measurements | 4. Fair Value Measurements The Company's assets and liabilities which are measured at fair value include short-term investments and warrants for common stock and, prior to the Merger, included warrants for preferred stock (“Preferred Warrants”) and warrants for common stock related to the convertible promissory notes (“Convertible Promissory Note Warrants”). All assets and liabilities recorded at fair value are revalued at each measurement period. Private CalciMedica elected the fair value option for the convertible promissory notes and estimated the fair value based on a discounted cash flow analysis, a form of the Income Approach. Several different settlement scenarios were considered, and probability weighted to arrive at the final valuation. Increases or decreases in the fair value of the convertible promissory notes can result from updates to assumptions such as the expected timing or probability of the different settlement scenarios, or changes in discount rates. Judgment is used in determining these assumptions as of the initial valuation date and at each subsequent reporting period. Updates to assumptions could have a significant impact on our results of operations in any given period. The Preferred Warrants were valued using the Hybrid Method (“Hybrid Method”). This method incorporates Private CalciMedica’s near-term liquidity event prospects utilized in conjunction with the Option Pricing Method (“OPM”) framework, representing an alternative exit, to calculate an implied overall value of Private CalciMedica. This value was, in turn, allocated to Private CalciMedica’s various equity classes. The Convertible Promissory Note Warrants were valued using a series of Monte Carlo simulations and Black-Scholes to determine the fair value, probability weighted for difference scenarios. The Monte Carlo simulations determined the liquidity event price. Black-Scholes was used with the remaining contractual term of the warrants after the respective event date. As of March 31, 2023, the Convertible Promissory Note Warrants were valued using the common stock price on the day of conversion. See further discussion in Note 5 - Convertible Promissory Notes and Convertible Promissory Note Warrants. The Common Warrants were valued using Black-Scholes utilizing the following inputs; (i) a risk-free interest rate; (ii) volatility based on the expected term of the Common Warrant; (iii) and an exercise price and stock price on the date of the transaction. Several different scenarios were considered, and probability weighted to arrive at the final valuation. Increases or decreases in the fair value of the Common Warrants can result from updates to assumptions such as the expected timing or probability of the different settlement scenarios. Judgment is used in determining these assumptions as of the initial valuation date and at each subsequent reporting period. Updates to assumptions could have a significant impact on our results of operations in any given period. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible. The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following three levels: • Level 1: Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date. • Level 2: Inputs (other than quoted prices included in Level 1) that are either directly or indirectly observable for the asset or liability. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. • Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The following tables present information about the Company’s financial assets measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values (in thousands):
|  | March 31, 2024 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Current assets: |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  | $ | 6,133 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,133 |
Commercial paper |  |  | — |  |  |  | 500 |  |  |  | — |  |  |  | 500 |
Total cash equivalents |  |  | 6,133 |  |  |  | 500 |  |  |  | — |  |  |  | 6,633 |
Short-term investments: |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  |  | — |  |  |  | 1,210 |  |  |  | — |  |  |  | 1,210 |
Commercial paper |  |  | — |  |  |  | 17,745 |  |  |  | — |  |  |  | 17,745 |
Total short-term investments |  |  | — |  |  |  | 18,955 |  |  |  | — |  |  |  | 18,955 |
Total assets measured at fair value |  | $ | 6,133 |  |  | $ | 19,455 |  |  | $ | — |  |  | $ | 25,588 |
Money market funds are highly liquid investments which are actively traded. The pricing information on the Company’s money market funds is based on quoted prices in active markets for identical securities. This approach results in the classification of these securities as Level 1 of the fair value hierarchy. During the three months ended March 31, 2024, there were no transfers between Level 1, Level 2 and Level 3. The following table presents information about the Company’s financial liabilities measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values (in thousands).
|  | March 31, 2024 |
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |
Warrant Liability |  | $ | — |  |  | $ | — |  |  | $ | 5,600 |  |  | $ | 5,600 |
Total liabilities measured at fair value |  | $ | — |  |  | $ | — |  |  | $ | 5,600 |  |  | $ | 5,600 |
No fair value liabilities existed as of December 31, 2023. The following provides a reconciliation for all liabilities measured at fair value using Level 3 inputs for the three months ended March 31, 2024 (in thousands):
Warrant liability |  |  |
Balance at December 31, 2023 |  | $ | — |
Initial Fair Value of Warrants |  |  | 11,190 |
Change in Fair Value of Preferred Warrants |  |  | (5,590 | )
Balance at March 31, 2024 |  | $ | 5,600 |
The following table presents information as to cost, unrealized gains and losses and fair value determination of the Company’s financial assets measured at fair value on a recurring basis (in thousands):
|  | March 31, 2024 |
|  | Amortized Cost |  |  | Unrealized Gains |  |  | Unrealized Losses |  |  | Aggregate Fair Value |
Current assets: |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents: |  |  |  |  |  |  |  |  |  |  |  |
Money market funds |  | $ | 6,133 |  |  | $ | — |  |  | $ | — |  |  | $ | 6,133 |
Commercial paper |  |  | 500 |  |  |  | — |  |  |  | — |  |  |  | 500 |
Total cash equivalents |  |  | 6,633 |  |  |  | — |  |  |  | — |  |  |  | 6,633 |
Short-term investments: |  |  |  |  |  |  |  |  |  |  |  |
Corporate debt securities |  |  | 1,210 |  |  |  | — |  |  |  | — |  |  |  | 1,210 |
Commercial paper |  |  | 17,762 |  |  |  | — |  |  |  | (17 | ) |  |  | 17,745 |
Total short-term investments |  |  | 18,972 |  |  |  | — |  |  |  | (17 | ) |  |  | 18,955 |
Total assets measured at fair value |  | $ | 25,605 |  |  | $ | — |  |  | $ | (17 | ) |  | $ | 25,588 |
As of March 31, 2024, the contractual maturities of all available-for-sale investments were less than 12 months. The Company periodically reviews the available-for-sale for other-than-temporary impairment loss. All of the Company’s short-term investments were in unrealized loss positions as of March 31, 2024. The Company’s unrealized losses from short-term investments as of March 31, 2024, were caused by interest rate increases and not by an unfavorable change in the credit quality associated with these securities. The Company does not intend to sell the investments before recovery of their amortized cost basis, which may be maturity. Therefore, the Company believes these losses to be temporary and as a result, did no t recognize any other-than-temporary losses as of March 31, 2024.

X
- Definition The entire disclosure for derivatives and fair value of assets and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//815/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//820/tableOfContent + Details
Name: | us-gaap_DerivativesAndFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration